Biogen to Present at the Guggenheim 5th Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Guggenheim 5th Annual Healthcare Conference. The webcast will be live on Wednesday, December 13, 2017 at 12:00 p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available following the presentation.

About BiogenThrough cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171207005141/en/

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Source: Biogen Inc.

You May Also Be Interested In

• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
• Alibaba Group Announced Pricing of HK$80 Billion Placing of New Shares in Hong Kong
• Humaans Expands Into US Payroll As It Accelerates US Growth